Rytmonorm

Rytmonorm

propafenone

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Propafenone HCl
Indications/Uses
Prophylaxis & treatment of ventricular & supraventricular tachyarrhythmias including atrial fibrillation, atrial tachycardia & Wolff-Parkinson-White syndrome; ventricular & supraventricular extrasystoles.
Dosage/Direction for Use
Adult 450-600 mg daily. Max: 900 mg daily. For treatment of ventricular rhythm disturbances careful drug monitoring is required.
Administration
Should be taken with food: Swallow whole, do not chew/crush.
Contraindications
Manifest heart failure; cardiogenic shock (except for shock induced by arrhythmia); severe bradycardia w/in 3 mth after MI; preexisting high degree SA, AV & intraventricular disorders of impulse conduction; sick sinus syndrome; manifest disorders of electrolyte balance; severe obstructive pulmonary disease; marked hypotension, myasthenia gravis.
Special Precautions
Impaired function of liver or kidneys; 1st trimester of pregnancy, lactation; elderly or patients w/ severely impaired myocardial function, dosage must be carefully titrated. May impair ability to drive or operate machinery. May alter both pacing & sensing thresholds of artificial pacemakers.
Adverse Reactions
Occasionally, anorexia, sensation of repletion, nausea, vomiting, bitter taste, numbness of mouth. Sporadically blurred vision; vertigo; allergic skin reactions; circulatory dysregulation in orthostasis. Rarely, fatigue, headache, psychic disorders, extrapyramidal symptoms; bradycardia, SA, AV or intraventricular blocks. Cholestasis. Risk of eliciting ventricular tachycardia or ventricular flutter, fibrillation; diminution of potency & drop in sperm count (high dose); very rarely, fully reversible decrease of white cell, granulocyte & platelet counts; agranulocytosis, rarely observed. Bronchial spasm, convulsion (following overdose).
Drug Interactions
Effect may be potentiated by local anesth, β-blockers, TCAs. May increase plasma level of propranolol, metoprolol, desipramine, cyclosporin, digoxin, theophylline. Plasma conc may rise when taken simultaneously w/ cimetidine or quinidine. May enhance effect of anticoagulant. Simultaneous administration w/ phenobarb or rifamycin may decrease propafenone plasma conc, possibly in subtherapeutic levels.
MIMS Class
Cardiac Drugs
ATC Classification
C01BC03 - propafenone ; Belongs to class Ic antiarrhythmics.
Presentation/Packing
Form
Rytmonorm film-coated tab 150 mg
Packing/Price
50's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in